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Secondary metabolites (or natural products) are often
synthesized by multi-modular, multi-domain proteins
called non-ribosomal peptide synthetases (NRPS) and
polyketide synthases (PKS). Various well-known metabo-
lites produced by microorganisms are listed in Table 1,
and examples of structures are shown in Fig. 1. In par-
ticular, Streptomyces species are known for their ability to
produce a wide variety of secondary metabolites such as
antibiotics, herbicides, parasitocides, siderophores and
pharmacologically active substances including antitumour
agents and immunosuppressants. Genome sequencing
of Streptomyces coelicolor (Bentley et al., 2002) and S.
avermitilis (Omura et al., 2001) revealed over 20 gene
clusters for biosynthesis of secondary metabolites, while
only a few of their natural products were known prior to
sequencing. High-throughput genome sequencing of hun-
dreds of other bacterial species and strains is now rapidly
increasing the repertoire of identified gene clusters for
biosynthesis of natural products (Donadio et al., 2007).
Here we give a brief update of the current status of
genome mining and bioinformatic tools to identify novel
NRPS and PKS systems.
Polyketide and non-ribosomal peptide biosynthesis
Both NRPS and PKS systems are molecular assembly
lines for successive linking of multiple-amino/hydroxy
acids or acyl-CoA precursors, respectively, into complex
polymers which are often further modified into unique
structures (Table 1, Fig. 1). The basic steps of both
systems are initiation, elongation and termination per-
formed by separate modules of the synthases (Fig. 2).
These modules and others are usually encoded in large
gene clusters (Khosla et al., 1999; Crosa and Walsh,
2002; Donadio et al., 2007; Rokem et al., 2007).
Non-ribosomal peptide synthetase modules can
contain four principal domains (Fig. 2A): an adenylation
domain (A) that selects, activates and loads the building
blocks (proteinogenic and non-proteinogenic amino acids
or carboxylic acids), a thiolation domain (T), also known
as peptidyl carrier protein (PCP) that covalently fixes the
amino acid on the synthetase, a condensation domain (C)
that catalyses the peptide bond formation, and a thio-
esterase domain (Te) that releases the assembled
peptide from the synthetase (Sieber and Marahiel, 2005;
Wenzel and Muller, 2005). The diversity in structure and
composition of the products is achieved due to different
specificities of the A domains and further modifications
by gene cluster-embedded or stand-alone additional
domains such as methyltransferase (MT), epimerization
(E), cyclization (Cy) and others (Walsh et al., 2001). The
assembled final peptide structures range from linear
[such as the pentadecapeptide gramicidin (Kessler et al.,
2004)], to branched [such as vibriobactin (Keating et al.,
2000)], partially cyclic [such as daptomycin (McHenney
et al., 1998)], cyclic [such as gramicidin S (Erlanger and
Goode, 1960)] or bicyclic [such as actinomycin (Pfennig
et al., 1999)].
Polyketide synthase modules can contain four core
domains (Fig. 2B): an acyltransferase (AT) domain that
selects and activates the acyl-CoA building blocks (such
as acetyl-CoA, malonyl-CoA, methylmalonyl-CoA and
ethylmalonyl-CoA), an acyl carrier (ACP) domain, a keto-
acylsynthase (KS) condensation domain and a releasing
thio-esterase (Te) domain. The modules may contain other
modification domains such as ketoreductase (KR), dehy-
dratase (DH) and enoylreductase (ER). Polyketide syn-
thases generate enzyme-bound ketoacyl intermediates in
stepwise decarboxylative condensations between the
extender building blocks and the growing polyketide chain
in a process similar to fatty acid synthesis. An example of
such an assembly process is shown in Fig. 3.
Prediction of structure of non-ribosomally
synthesized peptides
In most of the NRPS systems known so far, the order and
structure of building blocks present in the secondary*For correspondence. E-mail r.siezen@cmbi.ru.nl.
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Table 1. Examples of microbial natural prod-
ucts produced by NRPS/PKS systems.Natural product Microorganism NRP/PK
Antibiotics
Penicillin Penicillium chrysogenum (fungi) NRP
Bacitracin Bacillus licheniformis NRP
Tyrocidin Bacillus brevis NRP
Cephalosporin Streptomyces clavuligerus NRP
Erythromycin Saccharopolyspora erythrea PK
Tetracycline Streptomyces aureofaciens PK
Actinomycin Streptomyces chrysomallus NRP
Antitumour agents
Dolastatin 10 Symploca species (cyanobacteria) NRP
Bleomycin Streptomyces verticillus Hybrid NRP/PK
Chondramide Chondromyces crocatus Hybrid NRP/PK
Epothilone Sorangium cellulosum Hybrid NRP/PK
Immunosuppressants
Cyclosporin Tolypocladium inflatum (fungi) NRP
Rapamycin Streptomyces hygroscopicus PK
FK506 Streptomyces sp. PK
FK520 Streptomyces hygroscopicus PK
Protease inhibitors
Anabaenopeptin Anabaena flos-aquae (cyanobacteria) NRP
Oscillamide Oscillatoria agardhii (cyanobacteria) NRP
Siderophores
Mycobactin Mycobacterium tuberculosis NRP
Bacillibactin Bacillus subtilis NRP
Enterobactin Escherichia coli NRP
Yersiniabactin Yersinia pestis Hybrid NRP/PK
Toxins
Mycolactone Mycobacterium ulcerans PK
Naphthazarins Fusarium oxysporum (fungi) PK
HC-toxin Cochliobolus carbonum (fungi) NRP
Bacteria unless otherwise indicated.
N
S
O
O
OH
HO
O
Echinomycin Vancomycin
Epothilones C (R=H) and D (R=CH3)
O
OCH2CO2H
H3CO
OH
OH
H3CCO2
OH
O
NH
OH
O
O
O
O
O
OH
OH
O
O
HO
O
O
HO N(CH3)2
OH
OCH3
Erythromycin A Rifamycin B
R
a c
b
OO
H
N
O
N
H
O
NH2
O
H
N
O
NH
O
H
N
OH
HO
O
NH
O N
H
Cl
HO
O
O
O
O OH
HOOH
NH2
HO
O
OH
OH
Cl
HO
H
H
H
HN N N
O
N N NH
O
N
H
H
N
N
N
N
N
O
O
O
O
O
OO
OS
SCH3O
O
H
Fig. 1. Examples of some chemical structures of (A) polyketides, (B) non-ribosomal peptides and (C) mixed NRP-PK compounds. Reprinted
with permission from Watanabe and Oikawa (2007). Copyright Royal Society of Chemistry.
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polypeptide product are reflected by the modular architec-
ture of the NRPS. This relation between the template and
the product is referred to as co-linearity rule. The speci-
ficity of A domains as well as the role of the other modi-
fying domains will specify the composition of the produced
polypeptide. General rules for predicting substrate speci-
ficity of A domains were initially developed based on the
crystal structure of an adenylation domain of gramicid
in synthetase (Stachelhaus et al., 1999; Challis et al.,
2000). The NRPSpredictor (http://www.ab.informatik.uni-
tuebingen.de/toolbox) uses transductive support vector
machines (TSVMs) as a predictive tool for detecting sub-
strate specificities of A domains (Rausch et al., 2005)
based on the physicochemical properties of substrate-
binding pocket residues.
In silico genome screening for NRPS/PKS
gene clusters
There are several bioinformatic tools available for
searching NRPS/PKS systems in genome sequences.
The NRPS-PKS tool is web-based software (http://
www.nii.res.in/nrps-pks.html) for analysing the large multi-
enzymatic, multi-domain megasynthases (Ansari et al.,
2004). The results of these analyses have been organized
as four searchable databases for elucidating domain
organization and substrate specificity of NRPS and
PKS. These databases provide an interface to correlate
chemical structures of these natural products with the
domains and modules in the corresponding PKS
or NRPS. ASMPKS is a web-based tool (http://gate.
smallsoft.co.kr:8008/~hstae/asmpks/index.html) for com-
putational analysis of PKS systems against genome
sequences (Tae et al., 2007). The ASMPKS can predict
functional modules for each protein sequence, estimate
the chemical composition of a polyketide synthesized
from the modules, and display the carbon chain structure
on the web interface. Another recent method to accurately
predict PK/NRP structures from genome sequences is
described by Minowa and colleagues (2007). Norine
(http://bioinfo.lifl.fr/norine) is a platform that includes a
database of non-ribosomal peptides (currently more than
Fig. 2. Basic steps during (A) non-ribosomal
peptide synthesis and (B) polyketide
synthesis. Adapted with permission from
Donadio and colleagues (2007). Copyright
Royal Society of Chemistry.
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700) together with tools for their analysis. The Norine
database stores peptide structures as well as various
annotations such as the biological activity, produc-
ing organisms, bibliographical references and others
(Caboche et al., 2008).
Analysis of over 220 completed bacterial genomes
up to 2005 revealed that PKS and NRPS systems
are mainly found in actinobacteria, b-proteobacteria,
g-proteobacteria, firmicutes and cyanobacteria (Donadio
et al., 2007). We have now analysed the 140 most
recently sequenced microbial genomes (July 2007–April
2008; GOLD database http://www.genomesonline.org/)
using Hidden Markov Model profiles of all core domains of
both NRPS and PKS. Many of these genomes are publicly
accessible in the NCBI database but have not been
described in the scientific literature yet (Siezen and
Wilson, 2008). Numerous NRPS/PKS systems were
found, and Table 2 lists the genomes with three or more
systems; several are described in more detail below. They
are mainly found in microorganisms with genomes larger
than 4 Mb isolated from soil or aquatic environments. In
addition, at least two NRPS or PKS systems are predicted
in Yersinia pseudotuberculosis IP 31758, Azorhizobium
caulinodans ORS 571, Marinomonas sp. MWYL1 and
Bacillus cereus cytotoxis NVH 391-98, while at least one
system is predicted in Escherichia coli HS, Coxiella bur-
netii Dugway 7E9-12, Enterobacter sakazakii ATCC BAA-
894, Staphylococcus aureus ssp. aureus Mu3, Vibrio
harveyi BB120, Serratia proteamaculans 568, Delftia
acidovorans SPH-1, Salmonella enterica arizonae sv.
62:z4,z23 RSK2980, Klebsiella pneumonia MGH78578
and Kineococcus radiotolerans SRS30216. Quite a
number of the latter bacteria are human pathogens.
Recently sequenced microbial genomes with
large potential for production of NRPS/PKS
natural products
Sorangium cellulosum is a soil-dwelling d-
proteobacterium of the group myxobacteria. The genus
Sorangium synthesizes approximately half of the second-
ary metabolites isolated from myxobacteria, including the
anticancer metabolite epothilone. Seventeen secondary
metabolite loci are encoded in the genome of strain So
ce56 (Schneiker et al., 2007), mostly PKS and NRPS
systems (Table 2). Known products are chivosazol,
etnangien and myxochelin, while others are still unknown.
Metabolites secreted by S. cellulosum known as
epothilones have been noted to have antineoplastic activ-
ity. This has led to the development of analogues that
mimic its activity. One such analogue, known as Ixabepi-
lone, is a US Food and Drug Administration (FDA)-
Fig. 3. Biosynthetic pathway, module and domain organization of two polyketide synthases (Type I) (MlsA1 and MlsA2) responsible for
mycolactone core biosynthesis in Mycobacterium ulcerans. Reprinted with permission from http://www.med.monash.edu.au/microbiology/
research/stinear.html.
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approved chemotherapy agent for the treatment of meta-
static breast cancer.
The soil actinomycete Streptomyces griseus produces
the well-known antituberculosis agent streptomycin.
Recent sequencing of the genome of S. griseus IFO
13350 shows that it has 34 gene clusters or genes for
biosynthesis of secondary metabolites, of which 14 PKS
or NRPS gene clusters seem to be specific for this
species (Ohnishi et al., 2008). These clusters presumably
direct the synthesis of various as yet unknown secondary
metabolites.
Actinomycetes of the marine-dwelling genus Salin-
ispora are a rich source of drug-like molecules. Salin-
ispora strains are commonly isolated from tropical marine
sediment, and many isolates produce compounds that
inhibit cancer cells, such as salinosporamide A (Feling
et al., 2003). The Salinispora tropica CNB-440 genome
dedicates nearly 10% of its genome to natural product
assembly (Udwary et al., 2007), which is greater than S.
coelicolor and S. avermitilis as well as other secondary
metabolite-producing actinomycetes. The S. tropica
genome features PKS systems of every known formally
classified family, NRPS systems and several hybrid clus-
ters. The majority of the 17 biosynthetic loci are novel.
Genome sequencing is ongoing of Salinispora arenicola
CNS-205, a producer of the bioactive compounds stauro-
sporine and rifamycin which may be useful in the treat-
ment of cancer. Other marine actinobacteria are also
potential sources of bioactive natural products (Bull and
Stach, 2007)
Frankia species form a separate lineage among the
high % G+C Gram-positive Actinobacteria. They are fila-
mentous ‘euactinomycetes’ that grow by hyphal branching
and tip extension and thus resemble the antibiotic-
producing Streptomyces species. Frankia species form a
symbiotic nitrogen-fixing association with a number of
plants. These symbioses add a large proportion of new
nitrogen to several ecosystems. The genome of Frankia
sp. strain EAN1pec has all housekeeping genes neces-
sary for saprophytic existence plus genes for sporulation,
vesicle development, symbiosis, N2 fixation and second-
ary metabolite production. Ten putative NRPS/PKS
Table 2. Recently sequenced bacterial genomes (1 July 2007 to April 2008) with at least three predicted NRPS/PKS gene clusters.
Species Habitat
Genome
size (Mb)
Gene clusters
(predicted)
Reference and/or
NCBI code
Sorangium cellulosum So ce56 Soil 13.0 3 NRPS Schneiker et al. (2007)
6 PKS NC_010162
4 NRPS/PKS
Salinispora tropica CNB-440 Marine, sediment 5.2 3 NRPS Udwary et al. (2007)
6 PKS NC_009380
4 NRPS/PKS
Streptomyces griseus IFO13350 Soil 8.5 9 NRPS Ohnishi et al. (2008)
5 PKS NC_010572
4 NRPS/PKS
Salinispora arenicola CNS205 Marine, sediment 5.8 4 NRPS NC_009953
2 NRPS/PKS
2 PKS
2 ambiguous PKS
Frankia sp. EAN1pec Plant symbiont, soil 9.0 2 NRPS NC_009921
3 PKS
5 ambiguous PKS
Bacillus amyloliquefaciens FZB42 Rhizosphere-colonizing, soil 3.9 4 NRPS Chen et al. (2007)
2 PKS NC_009725
2 NRPS/PKS
1 ambiguous NRPS
Herpetosiphon aurantiacus ATCC 23779 Aquatic 6.4 5 NRPS NC_009972
4 NRPS/PKS
Pseudomonas aeruginosa PA7 Soil, aquatic, host (human) 6.6 5 NRPS NC_009656
Xanthobacter autotrophicus Py2 Soil, aquatic, sediment 4.8 2 NRPS NC_009720
2 ambiguous PKS
1 NRPS/PKS
Clostridium kluyveri DSM 555 Aquatic, mud 4.0 1 NRPS Seedorf et al. (2008)
3 NRPS/PKS NC_009706
Bacillus pumilus SAFR-032 Soil 3.7 2 NRPS Gioia et al. (2007)
1 NRPS/PKS NC_009848
Citrobacter koseri ATCC BAA-895 Soil, aquatic, food, human intestine 4.7 3 NRPS/PKS NC_009792
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clusters were identified in the genome sequence of strain
EAN1pec.
Bacillus amyloliquefaciens is a Gram-positive bacte-
rium belonging to the firmicutes. It is member of a group of
free-living soil bacteria known to promote plant growth
and suppress plant pathogenic bacteria and fungi. The B.
amyloliquefaciens FZB42 genome reveals an unexpected
potential to produce secondary metabolites, with more
than 8.5% of the genome devoted to synthesizing antibi-
otics and siderophores by NRPS and PKS pathways
(Chen et al., 2007). Besides five gene clusters known
from Bacillus subtilis to mediate biosynthesis of second-
ary metabolites (surfactin, fengycin, bacillibactin, bacil-
ysin, bacillaene), an additional four giant gene clusters
were identified for biosynthesis of bacillomycin D, macro-
lactin, difficidin and a putative siderophore. Bacillus
spores are notoriously resistant to unfavourable condi-
tions such as UV radiation, g-radiation, H2O2, desiccation,
chemical disinfection or starvation. Bacillus pumilus
SAFR-032 spores and vegetative cells exhibit elevated
resistance to UV radiation and H2O2 compared with other
Bacillus species, and its genome sequence provides
insight into numerous DNA repair and oxidative stress
pathways (Gioia et al., 2007). It also encodes three
NRPS/PKS systems of unknown function.
Clostridium kluyveri DSM555, a strictly anaerobe Firmi-
cute, was isolated from canal mud in the Netherlands. It is
unique among clostridia in that it can grow on ethanol and
acetate as sole energy sources, producing butyrate,
caproate and H2 (Seedorf et al., 2008). Furthermore, it is
biotechnologically interesting as the genome sequence
predicts that it could ferment ethanol and glycerol to 1,3-
propanediol. Quite unexpected in an anaerobe Firmicute
is the presence of three hybrid PKS-NRPS clusters of
unknown function, and one NRPS gene cluster which is
predicted to synthesize a yersiniabactin/pyochelin-like
siderophore.
Chloroflexi are a class of eubacteria that produce
energy through photosynthesis. They make up the bulk of
the filamentous anoxygenic phototrophs (formerly known
as green non-sulfur bacteria). The phylum Chloroflexi
accommodates additional genera, including filamentous
but non-phototrophic species. Herpetosiphon aurantiacus
is a non-phototrophic, strictly aerobic, gliding bacterium.
Herpetosiphon spp. have been found in soil, freshwater
and sewage treatment plants and grow in microbial mats.
The genome of H. aurantiacus strain ATCC 23779 is pre-
dicted to encode nine NRPS/PKS systems of unknown
function.
Xanthobacter autotrophicus, an a-proteobacterium, is
a nitrogen-fixing methylotroph, commonly isolated from
organic-rich soil, sediment and water. Xanthobacter
autotrophicus strain Py2 is unique in that it can use
propene as a sole carbon and energy source, converting
it to epoxypropane using an alkene-specific mono-
oxygenase. The monooxygenase gene and other genes
involved in alkene degradation are located on a 320 kb
megaplasmid. The genome sequence provides further
information on the production and regulation of the genes
involved in alkene degradation. The genome also has five
putative NRPS/PKS gene clusters of as yet unknown
function.
High-throughput experimental screening for
NRPS/PKS gene clusters
The newly discovered gene clusters for NRP and PK
synthesis represent a tremendous source of novel bioac-
tive compounds, but in most cases the natural product is
unknown. Classical methods to characterize the products
include heterologous expression of gene clusters (Wenzel
and Muller, 2005), metabolic profiling and assay-guided
fractionation (Zazopoulos et al., 2003; McAlpine et al.,
2005). A novel ‘genomisotopic’ approach uses a combi-
nation of genomic sequence analysis and isotope-guided
fractionation to identify unknown compounds synthesized
by NRPS gene clusters (Gross et al., 2007). A phage-
display method was developed for high-throughput mining
of gene clusters encoding PKS and NRPS systems, which
can be applied to genomes of unknown sequence and
metagenomes (Yin et al., 2007), providing opportunities
for exploiting the potentially rich source of natural prod-
ucts from unculturable microbes.
Novel natural products and applications
The past decade has already seen numerous examples
of genetic engineering, metabolic engineering, rational
design, and directed evolution of NRPS and PKS systems
to provide novel compounds based on known NRPS/PKS
gene clusters for biosynthesis of natural products (Stach-
elhaus et al., 1996; Cane et al., 1998; Chartrain et al.,
2000; Du and Shen, 2001; Du et al., 2001). The impact
of systems biology to control and regulate secondary
metabolite production has only recently been addressed
(Rokem et al., 2007). The ever-increasing pace of micro-
bial genome sequencing is revealing a plethora of new
NRPS/PKS gene clusters, mostly of unknown function. A
major challenge for the next decade is to back this up with
characterization of the chemical structures and biological
activities of these secondary metabolites, so that we can
chart Nature’s unique repertoire of natural products and
exploit them for the directed synthesis of novel molecules
of biotechnological, agricultural and pharmaceutical utility.
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